The Minister of Health, Population and Hospital Reform, Professor Abderrahmane Benbouzid, raised several points related to the coronavirus (covid-19) pandemic in Algeria, in particular the acquisition of vaccine.
In a statement to the Echorouk News Channel, the Minister referred to the point related to Russian vaccine production in Algeria following the information relayed on the possibility of manufacturing the Russian vaccine in Algeria, affirming “that there are no contacts to manufacture a vaccine for coronavirus in Algeria”.
It is worth recalling that the President of Russian Sovereign Wealth Fund, kirill dmitriev, revealed, friday december 2, that the anti coronavirus vaccine “sputnik v” could be produced in Algeria.
“In africa, the production of the vaccine against the coronavirus sputnik v could take place in Algeria and egypt,” he announced at a meeting to present the russian vaccine against covid-19.
a few days later, on December 8, The Russian Ambassador to Algeria broached the same issue.
The Ambassador had mentioned, in an interview with the Sputnik agency, that Algeria could, in fact, locally produce the sputnik v. coronavirus vaccine.
“We have discussed this issue during our meetings with [Algeria’s] Health Minister and the Minister of Pharmaceutical Industry. Russia is ready to cooperate with Algeria to design a vaccine on the local level, and I mean here the Russian Direct Investment Fund, which deals with the distribution of the vaccine outside the country,” Belyaev said.
“It [the fund] proposes multiple options of engagement, including direct acquisition, transfer of technology, joint production, and participation in the third phase of tests – we have offered all that to the Algerian side,” the Ambassador added.
Noting that Russia’s Sputnik V became the world’s first registered vaccine against COVID-19 on 11 August. The vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology, with support from the sovereign wealth fund, and is currently completing phase 3 clinical trials.